Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKD-981 in Degenerative Knee Osteoarthritis
NCT06954766Phase 2Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Apr 2025
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) (4 arms), sponsored by Chong Kun Dang Holdings. Primary endpoint: Visual Analog Scale for weight-bearing knee pain at 6 weeks. Started Apr 2025; status: completed.
02
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06954766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06954766.